Colon Cancer News and Research

Latest Colon Cancer News and Research

Specific sedentary behavioral patterns linked with risk of young-onset colorectal cancer

A new study in JNCI Cancer Spectrum has identified a connection between prolonged time spent sitting while watching TV and increased risk of colorectal cancer for younger Americans.

5 Feb 2019

Discovery of proteins that control mucin secretion reveals clues to treating colon, airway diseases

Cells produce mucins at a constant rate, and when exposed to an allergen or pathogen, they produce more mucin in a rapid burst. Both the constant and rapid mucin secretion is controlled by calcium.

1 Feb 2019

Researchers design interleukin protein to balance overshooting immune response

Small infections can be fatal: Millions of people die each year from sepsis, an overreaction of the immune system.

23 Jan 2019

White blood cells linked to for asthma, allergies may be used to eliminate colon cancer cells

A new Tel Aviv University study finds that eosinophils -- white blood cells that may have played an evolutionary role in combating parasites, but which are today responsible for chronic asthma and modern allergies -- may be used to eliminate malignant colon cancer cells.

23 Jan 2019

Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations

Colorectal Cancer has now become one of the leading causes of death. Studies indicate that smoking, low physical activities and high-fat diet are a major risk factor for colorectal cancer.

21 Jan 2019

Truncal mutations study suggests new direction in origins of cancer

Cancers most commonly arise because of a series of two to five mutations in different genes that combine to cause a tumor.

16 Jan 2019

Poo transplant can successfully treat patients with ulcerative colitis

Poo transplant or "Fecal microbiota transplantation" can successfully treat patients with ulcerative colitis, new research from the University of Adelaide shows.

16 Jan 2019

Scientists find link between colitis and colon cancer

Lingering inflammation in the colon is a known risk factor for colorectal cancer and now scientists report one way it resets the stage to enable this common and often deadly cancer.

14 Jan 2019

Ten year follow-up after negative colonoscopy related to reduced risk of colorectal cancer

Ten years after a negative colonoscopy, Kaiser Permanente members had 46 percent lower risk of being diagnosed with and were 88 percent less likely to die from colorectal cancer compared with those who did not undergo colorectal cancer screening, according to a study published today in JAMA Internal Medicine.

17 Dec 2018

Exercise may reduce colorectal cancer risk after weight loss

New research suggests that exercise is a key factor in reducing colorectal cancer risk after weight loss. According to the study, physical activity causes beneficial changes in the bone marrow. The study is published ahead of print in the American Journal of Physiology--Endocrinology and Metabolism.

13 Dec 2018

Study: Patients with cancer have worse outcomes after heart procedure

Research led by Keele University suggests that patients with cancer who undergo a common heart procedure have worse short-term clinical outcomes compared to non-cancer patients, in the largest study undertaken to date.

30 Nov 2018

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

Restricting the ability of cancer cells to metabolise sugar could make oncolytic viruses more effective at attacking them, suggests a study published today in the journal Cancer Research.

29 Nov 2018

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

The U.S. Food and Drug Administration today granted accelerated approval to Vitrakvi (larotrectinib), a treatment for adult and pediatric patients whose cancers have a specific genetic feature (biomarker).

27 Nov 2018

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

A University of Houston pharmaceutical scientist is developing a new drug which could bring relief to children suffering with Familial Adenomatous Polyposis, a rare genetic disorder characterized by hundreds - if not thousands - of colorectal polyps.

21 Nov 2018

Regenstrief scientist calls for precision surveillance for colon cancer screening

The interval at which an individual undergoes a repeat colonoscopy because of previous pre-cancerous polyps -- a practice known as "surveillance" -- should be tailored to the individual and not simply be determined by the results of prior colonoscopies, according to Regenstrief Institute research scientist Thomas F. Imperiale, M.D.

8 Nov 2018

Biological factors not responsible for racial differences in colorectal cancer incidence

A systematic review and meta-analysis from the Regenstrief Institute and Indiana University School of Medicine has found that, in spite of the higher incidence and death rate of colorectal cancer in blacks, no difference exists in the overall prevalence of advanced, precancerous polyps between average-risk blacks and whites who underwent a screening colonoscopy.

24 Oct 2018

CRC incidence rates among young adults across Europe increasing by 6% every year

Data from 20 European national cancer registries was used to analyze trends in incidence rates of young adults with CRC across Europe over the last 25 years.

23 Oct 2018

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Pre-operative treatment with a combination of the immune checkpoint inhibitors nivolumab and ipilimumab achieves major pathological responses in 100% of early-stage colon cancers with mismatch repair deficiencies, according to results reported at ESMO 2018 from the first exploratory phase II trial to investigate this approach.

22 Oct 2018

$Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer$

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Servier and Taiho Oncology, Inc. (U.S.), a subsidiary of Taiho Pharmaceutical Co., Ltd. (Japan), jointly announced today clinical data from the pivotal Phase III TAS-102 Gastric Study (TAGS) evaluating LONSURF® (trifluridine/tipiracil, TAS-102) versus placebo and best supportive care in patients with heavily pre-treated metastatic gastric cancer who have progressed or are intolerant to previous lines of therapy.

22 Oct 2018

Case Comprehensive Cancer Center wins NIH grant to study health disparities

The Case Comprehensive Cancer Center has received a three-year, $3,194,947 grant from the National Cancer Institute to investigate colorectal and breast cancer health disparities.

19 Oct 2018

Colon Cancer News and Research

Latest Colon Cancer News and Research

Specific sedentary behavioral patterns linked with risk of young-onset colorectal cancer

Discovery of proteins that control mucin secretion reveals clues to treating colon, airway diseases

Researchers design interleukin protein to balance overshooting immune response

White blood cells linked to for asthma, allergies may be used to eliminate colon cancer cells

Fiderstat could be used as chemopreventative drug for intestinal cancers caused by APC gene mutations

Truncal mutations study suggests new direction in origins of cancer

Poo transplant can successfully treat patients with ulcerative colitis

Scientists find link between colitis and colon cancer

Ten year follow-up after negative colonoscopy related to reduced risk of colorectal cancer

Exercise may reduce colorectal cancer risk after weight loss

Study: Patients with cancer have worse outcomes after heart procedure

Restricting cancer metabolism could make oncolytic viruses more effective at attacking tumors

FDA grants accelerated approval to oncology drug for treatment of key genetic driver of cancer

UH pharmaceutical scientist developing new drug to treat children with rare genetic disorder

Regenstrief scientist calls for precision surveillance for colon cancer screening

Biological factors not responsible for racial differences in colorectal cancer incidence

CRC incidence rates among young adults across Europe increasing by 6% every year

Immunotherapy achieves major pathological response in early-stage mismatch repair deficient colon cancer

Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer

Case Comprehensive Cancer Center wins NIH grant to study health disparities

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Colon Cancer News and Research

Latest Colon Cancer News and Research

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in